日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Brief Report: Exploratory Substudy of a Phase 2 Trial to Evaluate the Pharmacokinetic Effect of Once-Monthly Islatravir on Long-Acting Reversible Contraceptives

简报:一项评估每月一次注射伊斯拉曲韦对长效可逆避孕药药代动力学影响的 II 期试验的探索性子研究

Pham, Michelle; Wickremasingha, Prachi; Vargo, Ryan; Patel, Munjal; Nedrow, Katherine; Homony, Brenda; Robertson, Michael N; Plank, Rebeca M

Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1

每月一次口服伊斯拉曲韦的安全性、耐受性和药代动力学:一项针对1型人类免疫缺陷病毒感染低风险人群的2a期研究

Hillier, Sharon L; Bekker, Linda-Gail; Riddler, Sharon A; Hendrix, Craig W; Badal-Faesen, Sharlaa; Macdonald, Pippa; Nair, Gonasagrie; Lombaard, Johannes; Caraco, Yoseph; Peer, Avivit; Patel, Munjal; Vargo, Ryan; Homony, Brenda; Nedrow, Katherine; Evans, Barbara; Wickremasingha, Prachi; Zhou, Yun-Ping; Teal, Valerie; Hwang, Peggy; McMullan, Ciaran; Kaufman, Keith D; Robertson, Michael N; Plank, Rebeca M

Subgroup analysis of phase 2 study of ceftolozane/tazobactam in neonates and young infants with pyelonephritis

头孢洛扎/他唑巴坦治疗新生儿和婴幼儿肾盂肾炎的II期研究亚组分析

Roilides, Emmanuel; Bradley, John S; Lonchar, Julia; Huntington, Jennifer A; Wickremasingha, Prachi; Su, Feng-Hsiu; Bruno, Christopher J; Johnson, Matthew G